Re-engineering CD154 blockade for transplantation: Fc-free design to separate thrombotic risk from therapeutic function

Siwon Hwang, Miyeon Chun, Junho Chung

Open source

DOI
10.4285/ctr.26.0059
Published
2026-09-22
Container
Clinical Transplantation and Research
Publisher
The Korean Society for Transplantation
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4285/ctr.26.0059,
  title = {Re-engineering CD154 blockade for transplantation: Fc-free design to separate thrombotic risk from therapeutic function},
  author = {Siwon Hwang and Miyeon Chun and Junho Chung},
  year = {2026},
  journal = {Clinical Transplantation and Research},
  doi = {10.4285/ctr.26.0059},
  url = {https://doi.org/10.4285/ctr.26.0059}
}

RIS

TY  - JOUR
TI  - Re-engineering CD154 blockade for transplantation: Fc-free design to separate thrombotic risk from therapeutic function
AU  - Siwon Hwang
AU  - Miyeon Chun
AU  - Junho Chung
PY  - 2026
JO  - Clinical Transplantation and Research
DO  - 10.4285/ctr.26.0059
UR  - https://doi.org/10.4285/ctr.26.0059
ER  - 

APA

Hwang, S., Chun, M., & Chung, J. (2026). Re-engineering CD154 blockade for transplantation: Fc-free design to separate thrombotic risk from therapeutic function. Clinical Transplantation and Research. https://doi.org/10.4285/ctr.26.0059

Source records